These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
5. The applications of Wearable Cardioverter Defibrillators in Heart Failure and beyond. Rocco E; Angelini A; Simeone B; Grimaldi MC; Pinnacchio G; Narducci ML; Pelargonio G Clin Ter; 2023; 174(1):85-92. PubMed ID: 36655650 [TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the 'real world'? Boriani G; Vitolo M; Leyva F Eur J Heart Fail; 2022 Jul; 24(7):1223-1226. PubMed ID: 35717601 [No Abstract] [Full Text] [Related]
7. Implantable Cardioverter-Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta-Analysis. Gama F; Ferreira J; Carmo J; Costa FM; Carvalho S; Carmo P; Cavaco D; Morgado FB; Adragão P; Mendes M J Am Heart Assoc; 2020 Apr; 9(8):e015177. PubMed ID: 32290732 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Wang NC; Piccini JP; Gheorghiade M Heart Fail Rev; 2011 Sep; 16(5):477-80. PubMed ID: 21424741 [TBL] [Abstract][Full Text] [Related]
9. A wearable cardioverter-defibrillator vest as a diagnostic and therapeutic tool after COVID-19. Chyży T; Małecka B; Bednarek J; Mielnik M; Dębski M; Miszalski-Jamka T; Boczar K; Lelakowski J; Ząbek A Kardiol Pol; 2023; 81(7-8):800-801. PubMed ID: 37270834 [No Abstract] [Full Text] [Related]
11. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death]. Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients. Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ; Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234 [TBL] [Abstract][Full Text] [Related]
16. Trends amongst implantable cardioverter defibrillator patients in a tertiary cardiac centre in Singapore from 2002 to 2011. Chong DT; Tan BY; Ho KL; Teo WS; Ching CK Ann Acad Med Singap; 2013 Sep; 42(9):480-2. PubMed ID: 24162324 [No Abstract] [Full Text] [Related]
17. Value of implantable cardioverter-defibrillators in managing atrial fibrillation. Frisch DR Heart Rhythm; 2009 Jan; 6(1):9-10. PubMed ID: 19121794 [No Abstract] [Full Text] [Related]
19. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry. Schrage B; Uijl A; Benson L; Westermann D; Ståhlberg M; Stolfo D; Dahlström U; Linde C; Braunschweig F; Savarese G Circulation; 2019 Nov; 140(19):1530-1539. PubMed ID: 31476893 [TBL] [Abstract][Full Text] [Related]
20. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]